Allen Baharaff | President & Chief Executive Officer |
Liat Hayardeny | Chief Scientific Officer |
Yohai Stenzler | Chief Financial Officer |
Steve Seedhouse | Raymond James |
Thomas | H.C. Wainwright |
Rick | Cantor Fitzgerald |
Good day. Welcome to the Galmed Conference Call to discuss Financial Results for the First Quarter 2021. Today's conference is being recorded.
Before we begin, please note that we'll be making certain forward-looking statements on today's call, including those regarding financial results, statements and forecasts regarding anticipated timelines and expectations with respect to our regulatory and clinical development programs as well as other statements that relate to future events. These statements are based on the beliefs and expectations of management as of today and actual results, trends, timelines, and projections relating to our financial position and projected development programs and pipeline could differ materially.